WallStreetZenWallStreetZen

NASDAQ: PMCB
Pharmacyte Biotech Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Pharmacyte Biotech earnings were $12.0M for the trailing 12 months ending Jan 31, 2025, with N/A growth year over year. The latest PMCB earnings report on Jan 31, 2025 announced Q1 2025 earnings of -$3.0M, up 2.9% from last quarter. For the last reported fiscal year 2024 ending Apr 30, 2024, PMCB reported annual earnings of -$17.2M, with 299.4% growth.

PMCB earnings history

Current Revenue
$0.0
Current Earnings
$12.0M
Current Profit Margin
0%

PMCB Return on Equity

Current Company
30.3%
Current Industry
-2%
Current Market
34.1%
PMCB's Return on Equity (30.3%)... subscribe to Premium to read more.
High Return on Equity Performance

PMCB undefined

Current Company
21%
Current Industry
-0.4%
PMCB is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PMCB announces earnings.

PMCB undefined

Current Company
47.5%
Current Industry
5.9%
PMCB has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PMCB vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PMCB$20.25M$12.04MN/A$0.74
DWTX-$12.43M-$12.86MN/A-$12.52
ACXP-$14.10M-$14.10MN/A-$0.87
APRE-$14.23M-$12.96MN/A-$2.35
CARM-$52.16M-$60.48MN/A-$1.46
View Top Biotech Stocks

Pharmacyte Biotech Earnings Reports & History FAQ

What were Pharmacyte Biotech's earnings last quarter?

On PMCB's earnings call on Invalid Date, Pharmacyte Biotech (NASDAQ: PMCB) reported Q4 2024 earnings per share (EPS) of -$0.44, up 32.31% year over year. Total PMCB earnings for the quarter were -$3.05 million. In the same quarter last year, Pharmacyte Biotech's earnings per share (EPS) was -$0.65.

If you're new to stock investing, here's how to buy Pharmacyte Biotech stock.

Is Pharmacyte Biotech profitable or losing money?

As of the last Pharmacyte Biotech earnings report, Pharmacyte Biotech is currently profitable. Pharmacyte Biotech's net profit (also called net income) for the twelve months ending Jan 31, 2025 was $20.25 million, a 1,877.72% decrease year over year.

What was PMCB's earnings growth in the past year?

As of Pharmacyte Biotech's earnings date in Invalid Date, Pharmacyte Biotech's earnings has grown year over year. PMCB earnings in the past year totalled $12.04 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.